Search Results - "Monov S."

Self-Propagating High-Temperature Synthesis and Sintering of AlN–Y2O3–Al2O3 Composites by Zakorzhevskii, V. V., Kovalev, I. D., Monov, S. S.

“…Results of studies on the synthesis by the SHS method of aluminum nitride and AlN–Al 2 O 3 –Y 2 O 3 composites with a low oxygen impurity content are…”
Get full text

The Presence of Monosodium Urate Deposits in the Joints of Patients with Asymptomatic Hyperuricemia is Associated with a Higher Cardiovascular Risk, But Not with More Advanced Kidney Damage by Gancheva R., Koundurdjiev A., Kundurzhiev T., Kolarov Zl, Peteva P., Nikolova M., Koundurdjieva I., Yankova P., Monov S., Marinchev L.

“…To evaluate the association between asymptomatic hyperuricemia, renal damage and cardiovascular events and to investigate whether the presence of monosodium…”
Get full text

Adult Niemann-Pick disease type B with myositis ossificans: a case report by Shumnalieva, R, Monov, S, Shoumnalieva-Ivanova, V, Rashkov, R

“…Niemann-Pick Disease (NPD) is a rare autosomal recessive lysosomal lipid storage disorder. The disease is caused by gene mutations that affect the metabolism…”
Get full text

Efficacy of Denosumab on Bone Mineral Density and Microarchitecture in Postmenopausal Women With Osteoporosis With and Without Glucocorticoid Treatment by Petranova, T, Sheytanov, I, Monov, S, Peytcheva, V, Rashkov, R

Get full text

Classification criteria for neuropsychiatric systemic lupus erythematosus: do they need a discussion? by Monov, S, Monova, D

“…At the current stage, the criteria for making the diagnosis of SLE (ARA, 1982) include only two neuropsychiatric manifestations: seizures and psychoses. In…”
Get full text

Autoantibodies against C1q: view on association between systemic lupus erythematosus disease manifestation and C1q autoantibodies by Monova, D, Monov, S, Rosenova, K, Argirova, T

“…The mean ratio of IgG1/IgG2 (3.4 (2.1)) was similar to that reported in the literature for disease free subjects. 6 The percentage of IgG2 C1qAb relative to…”
Get full text

Serum miR-21 and miR-29a expression in systemic sclerosis patients by Shumnalieva, Russka, Kachakova, Darina, Kaneva, Radka, Kolarov, Zlatimir, Monov, Simeon

“…The aim of our study was to evaluate the expression levels of miR-21 and miR-29a in the serum of systemic sclerosis (SSc) patients and to determine their…”
Get more information

Self-Propagating High-Temperature Synthesis and Sintering of AlN-Y.sub.2O.sub.3-Al.sub.2O.sub.3 Composites by Zakorzhevskii, V. V, Kovalev, I. D, Monov, S. S

“…Results of studies on the synthesis by the SHS method of aluminum nitride and AlN-Al.sub.2O.sub.3-Y.sub.2O.sub.3 composites with a low oxygen impurity content…”
Get full text

Antiribosomal P antibodies in patients with lupus glomerulonephritis by Monova, D, Argirova, T, Monov, S

Get more information

226 Relapses of lupus nephritis – risk factors, incidence and impact of outcome by Monova, D, Monov, S

“…Background and aimsThe aim of this study was to review renal flare frequency, to identify potential risk factors for relapses, to assess the value of…”
Get full text

373 Association between disease activity, quality of life and quality of sleep in patients with systemic lupus erythematosus (sle) by Monova, D, Monov, S

“…Background and aimsThe aim of this study was to examine the association of SLE disease activity, quality of life and quality of sleep in patients diagnosed…”
Get full text

Whole peripheral blood miR-146a and miR-155 expression levels in Systemic lupus erythematosus patients by Shumnalieva, Russka, Kachakova, Darina, Shoumnalieva-Ivanova, Viara, Miteva, Polina, Kaneva, Radka, Monov, Simeon

“…Objective: To evaluate the diagnostic value of peripheral blood microribonucleic acid (miRNA, miR)-146a and miR-155 expression in systemic lupus erythematosus…”
Get full text

451 Prolonged remission in patients with lupus nephritis by Monova, D, Monov, S, Peneva, E

“…Background and aimsThe aim of this study is to assess the prevalence of prolonged remission in patients with lupus nephritis (LN) and its relationship with…”
Get full text

317 Dysregulation of mirnas expression levels and disease activity in sle patients by Shumnalieva, R, Kachakova, D, Monov, S, Kaneva, R, Choumnalieva-Ivanova, V, Kolarov, Z, Rashkov, R

“…Background and aimsAltered expression of miRNAs have been implicated in the pathogenesis of SLE due to their role in both the adaptive and innate immunity…”
Get full text

PRIMARY AND SECONDARY GLOMERULONEPHRITIDES 2 by Monova, D., Monov, S., Todorov, T., Soderberg, D., Kurz, T., Weiner, M., Eriksson, P., Segelmark, M., Jakuszko, K., Sebastian, A., Bednarz, Z., Krajewska, M., Wiland, P., Madziarska, K., Weyde, W., Klinger, M., Naidoo, J., Wearne, N., Jones, E., Swanepoel, C., Rayner, B., Okpechi, I., Endo, N., Tsuboi, N., Furuhashi, K., Matsuo, S., Maruyama, S., Clerte, M., Levi, C., Touzot, M., Fakhouri, F., Monge, C., Lebas, C., Abboud, I., Huart, A., Durieux, P., Charlin, E., Thervet, E., Karras, A., Smykal-Jankowiak, K., Niemir, Z. I., Polcyn-Adamczak, M., Whatmough, S., Sweeney, N., Fernandez, S., Hussain, M., Dhaygude, A., Gniewek, K., Manenti, L., Urban, M. L., Vaglio, A., Gintoli, E., Galletti, M., Buzio, C., Argirova, T., Wong, I., Ibrahim, F. H., Goh, B. L., Lim, T. S., Chan, M. W., Hiramtasu, R., Ubara, Y., Hoshino, J., Takaichi, K., Ghafoor, V., Sahay, M., Soma, J., Nakaya, I., Sasaki, N., Yoshikawa, K., Sato, H., Kaminskyy, V., ZAbi Ska, M., Ko Cielska-Kasprzak, K., Niemir, Z., Wozniczka, K., Swierzko, A., Cedzynski, M., Sokolowska, A., Szala, A., Arjunan, A., Mikhail, A., Shrivastava, R., Parker, C., Aithal, S., Gursu, M., Ozari, M., Yucetas, E., Sumnu, A., Doner, B., Cebeci, E., Ozkan, O., Aktuglu, M. B., Karaali, Z., Koldas, M., Ozturk, S., Marco, H., Picazo, M., Da Silva, I., Gonzalez, A.

Get full text

Clinical nephrology - miscellaneous by Bantis, C., Heering, P., Kouri, N.-M., Siekierka-Harreis, M., Stangou, M., Schwandt, C., Efstratiadis, G., Rump, L.-C., Ivens, K., Haddiya, I., Houssaini Squalli, T., Laouad, I., Ramdani, B., Bayahia, R., Dimas, G. G., Tegos, T. J., Spiroglou, S. G., Pitsalidis, C. G., Sioulis, A. S., Karamouzis, I. M., Savopoulos, C. G., Karamouzis, M. I., Orologas, A. G., Hatzitolios, A. I., Grekas, D. M., Maixnerova, D., Jancova, E., Rychlik, I., Rysava, R., Merta, M., Reiterova, J., Kolsky, A., Honsova, E., Skibova, J., Tesar, V., Kendi Celebi, Z., Calayoglu, R., Keven, K., Kurultak, I., Mescigil, P., Erbay, B., Karatan, O., Duman, N., Erturk, S., Nergizoglu, G., Kutlay, S., Sengul, S., Ates, K., Marino, F., Martorano, C., Bellantoni, M., Tripepi, R., Zoccali, C., Ishizuka, K., Harita, Y., Kajiho, Y., Tsurumi, H., Asano, T., Nishiyama, K., Sugawara, N., Chikamoto, H., Akioka, Y., Yamaguchi, Y., Igarashi, T., Hattori, M., Heering, P. J., Sahay, M., Monova, D. V., Monov, S. V., Wang, Y.-y., Cheng, H., Wang, G.-q., Dong, H.-r., Chen, Y.-p., Wang, C.-j., Tang, Y.-l., Buti, E., Dervishi, E., Bergesio, F., Ghiandai, G., Mjeshtri, A., Paudice, N., Caldini, A. L., Nozzoli, C., Minetti, E. E., Sun, L., Feng, J., Yao, L., Fan, Q., Ma, J., Wang, L., Kirsanova, T., Merkusheva, L., Ruinihina, N., Kozlovskaya, N., Elenshleger, G., Turgutalp, K., Karabulut, U., Ozcan, T., Helvaci, I.

Get full text

Intravenous immunoglobulin G in the treatment of patients with chronic glomerulonephritis: clinical experience lasting 15 years by Monova, Daniela, Belovezhdov, Nicolay, Altunkova, Iskra, Monov, Simeon

“…In our study, we collected data on 116 patients with biopsy-proven idiopathic or lupus glomerulonephritis who were treated with high doses of intravenous…”
Get more information